FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

10295511000001102: Sertraline 50mg tablets (Relonchem Ltd) 28 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35491701000001119 Sertraline 50mg tablets (Relonchem Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35491801000001111 Sertraline 50mg tablets (Relonchem Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Is a Sertraline 50mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Is pack of Sertraline 50mg tablets (Relonchem Ltd) false Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has active ingredient Sertraline hydrochloride false Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has active ingredient Sertraline false Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has AMP Sertraline 50mg tablets (Relonchem Ltd) true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sertraline true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has specific active ingredient Sertraline hydrochloride true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sertraline 50mg tablets (Relonchem Ltd) 28 tablet Has basis of strength substance Sertraline true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start